Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit.
作者信息
Bradburn M J, Clark T G, Love S B, Altman D G
机构信息
Cancer Research UK/NHS Centre for Statistics in Medicine, Institute of Health Sciences, Old Road, Oxford OX3 7LF, UK.
出版信息
Br J Cancer. 2003 Aug 18;89(4):605-11. doi: 10.1038/sj.bjc.6601120.
Abstract
摘要
相似文献
1
Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit.生存分析第三部分：多变量数据分析——选择模型并评估其充分性和拟合优度。
Br J Cancer. 2003 Aug 18;89(4):605-11. doi: 10.1038/sj.bjc.6601120.
2
Joint modeling of progression-free survival and death in advanced cancer clinical trials.晚期癌症临床试验中无进展生存期和死亡的联合建模。
Stat Med. 2010 Jul 20;29(16):1724-34. doi: 10.1002/sim.3918.
3
Survival analysis part I: basic concepts and first analyses.生存分析第一部分：基本概念与初步分析。
Br J Cancer. 2003 Jul 21;89(2):232-8. doi: 10.1038/sj.bjc.6601118.
4
Survivorship as an element of clinical trials in ovarian cancer.卵巢癌临床试验中的生存情况作为一个要素
Int J Gynecol Cancer. 2011 May;21(4):788-92. doi: 10.1097/IGC.0b013e31821bb717.
5
Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.前列腺、肺、结肠和卵巢癌（PLCO）筛查试验中的死亡审查过程。
Control Clin Trials. 2000 Dec;21(6 Suppl):400S-406S. doi: 10.1016/s0197-2456(00)00095-7.
6
Carcinoma of the ovary.卵巢癌
J Epidemiol Biostat. 2001;6(1):107-38.
7
Analysis of survival data with cross-effects of survival functions.具有生存函数交叉效应的生存数据分析。
Biostatistics. 2004 Jul;5(3):415-25. doi: 10.1093/biostatistics/5.3.415.
8
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.多变量预后模型：模型开发、评估假设与充分性以及测量和减少误差方面的问题。
Stat Med. 1996 Feb 28;15(4):361-87. doi: 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4.
9
Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.基于人群的研究：构建并验证用于预测有远处转移的上皮性卵巢癌患者生存结局的列线图。
BMC Cancer. 2021 May 25;21(1):609. doi: 10.1186/s12885-021-07977-4.
10
[Methodology of clinical trials].[临床试验方法学]
Rev Pneumol Clin. 2001 Nov;57(5 Pt 2):S13-6.
引用本文的文献
1
Identifying and characterizing commercially insured patients with HFpEF with high vs low health care resource utilization.识别和描述高医疗资源利用率与低医疗资源利用率的射血分数保留的心力衰竭商业保险患者。
J Manag Care Spec Pharm. 2025 Aug;31(8):741-751. doi: 10.18553/jmcp.2025.31.8.741.
2
Fatigue in long-term cancer survivors: prevalence, associated factors, and mortality. A prospective population-based study.长期癌症幸存者的疲劳：患病率、相关因素及死亡率。一项基于人群的前瞻性研究。
Br J Cancer. 2025 Jul 15. doi: 10.1038/s41416-025-03116-z.
3
Incidence, Trends and Survival of Oral Cavity Squamous Cell Carcinoma in Aotearoa New Zealand over 15 Years (2006-2020).15年间（2006 - 2020年）新西兰口腔鳞状细胞癌的发病率、趋势及生存率
Asian Pac J Cancer Prev. 2025 Jun 1;26(6):2015-2023. doi: 10.31557/APJCP.2025.26.6.2015.
4
Data-driven prior elicitation for Bayes factors in Cox regression for nine subfields in biomedicine.生物医学九个子领域中Cox回归中贝叶斯因子的数据驱动先验引出
PLoS One. 2025 May 23;20(5):e0322144. doi: 10.1371/journal.pone.0322144. eCollection 2025.
5
NLRP3 inflammasomes pathway: a key target for Metformin.NLRP3炎性小体通路：二甲双胍的关键靶点。
Inflammopharmacology. 2025 Apr;33(4):1729-1760. doi: 10.1007/s10787-025-01702-4. Epub 2025 Mar 5.
6
Associations of long-term exposure to nitrogen oxides with all-cause and cause-specific mortality.长期接触氮氧化物与全因死亡率和特定病因死亡率的关联。
Nat Commun. 2025 Feb 18;16(1):1730. doi: 10.1038/s41467-025-56963-y.
7
Differences in functional outcome of COVID-19 and non-COVID-19 patients with critical illness polyneuropathy/ myopathy: a multicenter cohort study.新型冠状病毒肺炎（COVID-19）与非COVID-19危重症多神经病/肌病患者功能转归的差异：一项多中心队列研究
J Neurol. 2025 Feb 11;272(3):197. doi: 10.1007/s00415-024-12873-5.
8
Impact of access to coronary angiography and percutaneous coronary intervention on in-hospital and five-year mortality in patients with acute coronary syndrome: a propensity-matched cohort study in Thailand.经皮冠状动脉介入治疗对急性冠状动脉综合征患者住院和五年死亡率的影响：泰国的倾向匹配队列研究。
Glob Health Res Policy. 2024 Nov 19;9(1):48. doi: 10.1186/s41256-024-00390-x.
9
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape.CD99通过特异性影响参与G2/M细胞周期阶段的FOXM1靶标，从而影响尤因肉瘤的遗传格局，对EWS::FLI1转录组产生作用。
J Cell Commun Signal. 2024 Aug 2;18(3):e12047. doi: 10.1002/ccs3.12047. eCollection 2024 Sep.
10
Sex-specific differences in alive hospital discharge following infrarenal abdominal aortic aneurysm repair.肾下腹主动脉瘤修复术后存活出院的性别差异。
Eur Heart J. 2025 May 7;46(18):1705-1716. doi: 10.1093/eurheartj/ehae675.
本文引用的文献
1
Survival analysis part II: multivariate data analysis--an introduction to concepts and methods.生存分析第二部分：多变量数据分析——概念与方法介绍
Br J Cancer. 2003 Aug 4;89(3):431-6. doi: 10.1038/sj.bjc.6601119.
2
Survival analysis part I: basic concepts and first analyses.生存分析第一部分：基本概念与初步分析。
Br J Cancer. 2003 Jul 21;89(2):232-8. doi: 10.1038/sj.bjc.6601118.
3
Developing a prognostic model in the presence of missing data: an ovarian cancer case study.在存在缺失数据的情况下开发预后模型：一项卵巢癌病例研究。
J Clin Epidemiol. 2003 Jan;56(1):28-37. doi: 10.1016/s0895-4356(02)00539-5.
4
An empirical comparison of statistical tests for assessing the proportional hazards assumption of Cox's model.评估Cox模型比例风险假设的统计检验的实证比较。
Stat Med. 1997 Mar 30;16(6):611-26. doi: 10.1002/(sici)1097-0258(19970330)16:6<611::aid-sim437>3.0.co;2-t.
5
Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates.比例风险回归分析中每个自变量的事件重要性。II. 回归估计的准确性和精确性。
J Clin Epidemiol. 1995 Dec;48(12):1503-10. doi: 10.1016/0895-4356(95)00048-8.
Zotero 插件